These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 29090079)

  • 1. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1.
    Johnson TB; Mechels K; Anderson RH; Cain JT; Sturdevant DA; Braddock S; Pinz H; Wilson MA; Landsverk M; Roux KJ; Weimer JM
    Sci Rep; 2018 Nov; 8(1):16161. PubMed ID: 30385778
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Meerschaut I; Rochefort D; Revençu N; Pètre J; Corsello C; Rouleau GA; Hamdan FF; Michaud JL; Morton J; Radley J; Ragge N; García-Miñaúr S; Lapunzina P; Bralo MP; Mori MÁ; Moortgat S; Benoit V; Mary S; Bockaert N; Oostra A; Vanakker O; Velinov M; de Ravel TJ; Mekahli D; Sebat J; Vaux KK; DiDonato N; Hanson-Kahn AK; Hudgins L; Dallapiccola B; Novelli A; Tarani L; Andrieux J; Parker MJ; Neas K; Ceulemans B; Schoonjans AS; Prchalova D; Havlovicova M; Hancarova M; Budisteanu M; Dheedene A; Menten B; Dion PA; Lederer D; Callewaert B
    J Med Genet; 2017 Sep; 54(9):613-623. PubMed ID: 28735298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
    Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
    Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.
    Sollis E; Deriziotis P; Saitsu H; Miyake N; Matsumoto N; Hoffer MJV; Ruivenkamp CAL; Alders M; Okamoto N; Bijlsma EK; Plomp AS; Fisher SE
    Hum Mutat; 2017 Nov; 38(11):1542-1554. PubMed ID: 28741757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms.
    Trelles MP; Levy T; Lerman B; Siper P; Lozano R; Halpern D; Walker H; Zweifach J; Frank Y; Foss-Feig J; Kolevzon A; Buxbaum J
    Mol Autism; 2021 Sep; 12(1):61. PubMed ID: 34588003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
    Lozano R; Gbekie C; Siper PM; Srivastava S; Saland JM; Sethuram S; Tang L; Drapeau E; Frank Y; Buxbaum JD; Kolevzon A
    J Neurodev Disord; 2021 Apr; 13(1):18. PubMed ID: 33892622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint contractures is a recurrent clinical feature of individuals with neurodevelopmental disorder due to FOXP1 likely gene disruptive variants.
    Peduto C; Cappuccio G; Zeuli R; Zanobio M; Torella A; Alkuraya FS; Joss S; Daolio C; Spinelli AM; Zampieri S; ; Nigro V; Brunetti-Pierri N
    Am J Med Genet A; 2024 Nov; 194(11):e63713. PubMed ID: 38924631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe speech impairment is a distinguishing feature of FOXP1-related disorder.
    Braden RO; Amor DJ; Fisher SE; Mei C; Myers CT; Mefford H; Gill D; Srivastava S; Swanson LC; Goel H; Scheffer IE; Morgan AT
    Dev Med Child Neurol; 2021 Dec; 63(12):1417-1426. PubMed ID: 34109629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autism spectrum disorder early in development associated with CHD8 mutations among two Chinese children.
    Wang J; Liu J; Gao Y; Wang K; Jiang K
    BMC Pediatr; 2018 Oct; 18(1):338. PubMed ID: 30376831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP1 haploinsufficiency: Phenotypes beyond behavior and intellectual disability?
    Myers A; du Souich C; Yang CL; Borovik L; Mwenifumbo J; Rupps R; Study C; Lehman A; Boerkoel CF
    Am J Med Genet A; 2017 Dec; 173(12):3172-3181. PubMed ID: 28884888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) With Language Impairment Accompanied by Developmental Disability Caused by Forkhead Box Protein 1 (FOXP1) Exon Deletion: A Case Report.
    Alenezi S; Alyahya A; Aldhalaan H
    Cureus; 2021 Dec; 13(12):e20595. PubMed ID: 35103171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and oxidative stress contribute to cognitive and motor impairment in FOXP1 syndrome.
    Wang J; Fröhlich H; Torres FB; Silva RL; Poschet G; Agarwal A; Rappold GA
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP1 mutations cause intellectual disability and a recognizable phenotype.
    Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF
    Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of FOXP1 syndrome: parent-reported medical signs and symptoms in 40 individuals.
    Koene S; Ropers FG; Wieland J; Rybak T; Wildschut F; Berghuis D; Morgan A; Trelles MP; Scheepe JR; Bökenkamp R; Peeters-Scholte CMPCD; Braden R; Santen GWE
    J Med Genet; 2024 Mar; 61(4):399-404. PubMed ID: 38123995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.